Clinical Focus
Business Focus
Spotlight
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Shingrix: Who Needs It and Who Doesn't?
Shingrix, the only shingles vaccine now available, is recommended for routine use in adults aged ≥50 years. As with most vaccines, exceptions always seem to exist, complicating the decision-making. As they say, the devil is in the details. Let's see how “devilish” you are today, with the 4-question quiz below.
1. A 40-year-old woman with no history of varicella disease thinks she received the vaccine as a child, but no records are available. She has been diagnosed with cancer and will be starting chemotherapy in 1-2 weeks. Since immunocompromised patients are at increased risk of shingles and its complications, should this woman start her 2-dose Shingrix series?
Related Videos
Related Content
Remdesivir Linked to Lower Mortality in Patients with COVID-19 Requiring Supplemental Oxygen
October 31st 2023Article
Remdesivir use was associated with increased survival among patients hospitalized with COVID-19 requiring supplemental oxygen across SARS-CoV-2 variants of concern, report researchers.
